Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Trangas

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Journal of Experimental & Clinical Cancer Research : CR|March 24, 1999
Poly(A)polymerase activity levels in breast tumour cytosolsA Scorilas, N Courtis, J Yotis, et al.
British Journal of Cancer|June 30, 2005
mRNA quantification and clinical evaluation of telomerase reverse transcriptase subunit (hTERT) in intracranial tumours of patients in the island of CreteA Yannopoulos, E Dimitriadis, A Scorilas, et al.
The International Journal of Biological Markers|October 1, 1996
delta IK17: an antigen expressed on human lymphocytesR Sotiriadou, D Kokkinopoulos, J Stinios, et al.
Blut|November 1, 1988
Relation between the activity of poly(A)polymerase and the levels of protein synthesis in the lymphocytes of patients with chronic lymphocytic leukemiaA Gounaris, N Courtis, G A Pangalis, et al.
Journal of Immunological Methods|July 16, 1987
A colorimetric assay for the determination of 5'-nucleotidase activityS Perez, N Courtis, D Kokkinopoulos, et al.
Oncogene|February 2, 1999
The polyadenylation inhibitor cordycepin (3'dA) causes a decline in c-MYC mRNA levels without affecting c-MYC protein levelsP Ioannidis, N Courtis, M Havredaki, et al.
The Journal of Biological Chemistry|June 3, 1994
Identification of a tripartite basal promoter which regulates human terminal deoxynucleotidyl transferase gene expressionD Bhaumik, B Yang, T Trangas, et al.
British Journal of Cancer|June 1, 2001
Overexpression of matrix-metalloproteinase-9 in human breast cancer: a potential favourable indicator in node-negative patientsA Scorilas, A Karameris, N Arnogiannaki, et al.
Anticancer Research|September 1, 1993
Cathepsin-D and c-erb-B 2 have an additive prognostic value for breast cancer patientsA Scorilas, J Yotis, D Gouriotis, et al.
Acta Haematologica|January 1, 1985
Poly(A)-polymerase activity in chronic lymphocytic leukemia of the B cell typeG A Pangalis, T Trangas, C J Papanastasiou, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Journal of Experimental & Clinical Cancer Research : CR|March 24, 1999
Poly(A)polymerase activity levels in breast tumour cytosolsA Scorilas, N Courtis, J Yotis, et al.
British Journal of Cancer|June 30, 2005
mRNA quantification and clinical evaluation of telomerase reverse transcriptase subunit (hTERT) in intracranial tumours of patients in the island of CreteA Yannopoulos, E Dimitriadis, A Scorilas, et al.
The International Journal of Biological Markers|October 1, 1996
delta IK17: an antigen expressed on human lymphocytesR Sotiriadou, D Kokkinopoulos, J Stinios, et al.
Blut|November 1, 1988
Relation between the activity of poly(A)polymerase and the levels of protein synthesis in the lymphocytes of patients with chronic lymphocytic leukemiaA Gounaris, N Courtis, G A Pangalis, et al.
Journal of Immunological Methods|July 16, 1987
A colorimetric assay for the determination of 5'-nucleotidase activityS Perez, N Courtis, D Kokkinopoulos, et al.
Oncogene|February 2, 1999
The polyadenylation inhibitor cordycepin (3'dA) causes a decline in c-MYC mRNA levels without affecting c-MYC protein levelsP Ioannidis, N Courtis, M Havredaki, et al.
The Journal of Biological Chemistry|June 3, 1994
Identification of a tripartite basal promoter which regulates human terminal deoxynucleotidyl transferase gene expressionD Bhaumik, B Yang, T Trangas, et al.
British Journal of Cancer|June 1, 2001
Overexpression of matrix-metalloproteinase-9 in human breast cancer: a potential favourable indicator in node-negative patientsA Scorilas, A Karameris, N Arnogiannaki, et al.
Anticancer Research|September 1, 1993
Cathepsin-D and c-erb-B 2 have an additive prognostic value for breast cancer patientsA Scorilas, J Yotis, D Gouriotis, et al.
Acta Haematologica|January 1, 1985
Poly(A)-polymerase activity in chronic lymphocytic leukemia of the B cell typeG A Pangalis, T Trangas, C J Papanastasiou, et al.
Pageof 4